Role of dihydrotestosterone in post-stroke peripheral immunosuppression after cerebral ischemia.
Stroke is a sexually dimorphic disease with male gender considered a disadvantage in terms of risk and disease outcome. In intact males, stroke induces peripheral immunosuppression, characterized by decreased splenocyte numbers and proliferation and altered percentages of viable T, B, and CD11b+ cells. To investigate whether the potent androgen and known immunomodulator, dihydrotestosterone (DHT), exacerbates post-stroke immunosuppression in castrated male mice after focal stroke, we evaluated the effect of middle cerebral artery occlusion (MCAO) on peripheral and central nervous system (CNS) immune responses in castrated mice with or without controlled levels of DHT. MCAO reduced spleen cell numbers in both groups, but altered T cell and B cell percentages in remaining splenocytes and concomitantly increased the percentage of CD11b+ blood cells solely in DHT-replaced animals at 24 h. Furthermore, DHT-replacement reduced splenocyte proliferation which was accompanied by an increased percentage of immunosuppressive regulatory T cells relative to castrates 96 h post-MCAO. In brain, the percentages of immune cell populations in the ischemic hemisphere relative to the non-ischemic hemisphere were similar between castrated and DHT-replaced mice after MCAO. These data suggest DHT modulates peripheral immunosuppression after MCAO but with relatively little effect on early immune response of the recovering CNS.
Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, OR 97123, USA.
Suzan
S
Dziennis
Kozaburo
K
Akiyoshi
Sandhya
S
Subramanian
Halina
H
Offner
Patricia D
PD
Hurn
D000704:Analysis of Variance; D000728:Androgens / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000276:immunology* / Q000473:pathology; D013196:Dihydrotestosterone / Q000494:pharmacology*; D007108:Immune Tolerance / Q000276:immunology*; D007155:Immunologic Factors / Q000494:pharmacology*; D020244:Infarction, Middle Cerebral Artery / Q000150:complications / Q000276:immunology / Q000473:pathology; D016131:Lymphocyte Subsets / Q000166:cytology*; D008297:Male; D016555:Matched-Pair Analysis; D051379:Mice; D008810:Mice, Inbred C57BL; D013154:Spleen / Q000166:cytology / Q000276:immunology; D020521:Stroke / Q000209:etiology / Q000276:immunology* / Q000473:pathology
D000728:Androgens; D007155:Immunologic Factors; D013196:Dihydrotestosterone
J Cereb Blood Flow Metab. 2009 Mar;29(3):606-20
19107136
Stroke. 2007 Feb;38(2 Suppl):770-3
17261736
Circulation. 2006 May 2;113(17):2105-12
16636173
J Cereb Blood Flow Metab. 2009 Aug;29(8):1454-62
19436313
Exp Transl Stroke Med. 2009 Oct 21;1:3
20142990
Am J Physiol. 1997 Oct;273(4):C1335-40
9357778
Endocrinology. 2007 May;148(5):2458-64
17303658
J Neuroimmunol. 2009 Jan 3;206(1-2):112-7
19058859
Nat Immunol. 2001 Sep;2(9):816-22
11526392
Exp Neurol. 2009 Jul;218(1):47-55
19371742
Stroke. 2003 May;34(5):1114-9
12690218
J Immunol. 2001 Aug 15;167(4):2060-7
11489988
Exp Neurol. 2006 May;199(1):191-200
16713598
Endocrinology. 1991 Nov;129(5):2471-6
1834454
Endocr Rev. 1996 Aug;17(4):369-84
8854050
Cell Immunol. 1997 Dec 15;182(2):99-104
9514700
J Cereb Blood Flow Metab. 2011 Jan;31(1):339-50
20588319
Nat Rev Neurosci. 2005 Oct;6(10):775-86
16163382
Stroke. 2009 Aug;40(8):2849-58
19443795
J Immunol. 1999 Jan 1;162(1):35-40
9886367
Am J Physiol. 1998 Jun;274(6):C1530-6
9696695
J Neurochem. 2001 Jun;77(5):1319-26
11389183
Restor Neurol Neurosci. 2009;27(3):163-79
19531872
J Exp Med. 2003 Sep 1;198(5):725-36
12939340
Endocrinology. 2007 Jul;148(7):3383-90
17395708
Int J Epidemiol. 1991 Dec;20(4):892-9
1800427
J Immunol. 2010 Apr 15;184(8):4087-94
20304826
Endocrinology. 2006 Apr;147(4):2028-34
16410299
Nat Med. 2009 Feb;15(2):192-9
19169263
J Cereb Blood Flow Metab. 2007 Sep;27(9):1553-62
17311081
J Neurosci Res. 2008 Aug 1;86(10):2227-34
18381759
J Endocrinol. 1980 Oct;87(1):37-46
7430915
J Neuroimmunol. 2004 Jan;146(1-2):144-52
14698857
Stroke. 2004 Apr;35(4):913-7
15001787
J Cereb Blood Flow Metab. 2010 Jul;30(7):1306-17
20145655
J Cereb Blood Flow Metab. 2006 May;26(5):654-65
16121126
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10873-8
9380727
J Neuroendocrinol. 2010 Sep;22(9):1013-22
20561156
J Immunol. 2006 Jun 1;176(11):6523-31
16709809
Stroke. 2007 Mar;38(3):1097-103
17255542
Endocrinology. 2001 Mar;142(3):1278-83
11181545
Arch Surg. 1996 Nov;131(11):1186-91; discussion 1191-2
8911259
Nat Rev Immunol. 2008 Sep;8(9):737-44
18728636
Horm Behav. 2008 May;53(5):693-705
18222446
Semin Reprod Med. 2009 May;27(3):229-39
19401954
Brain Res. 2001 Feb 23;892(2):255-62
11172772